Anika Therapeutics (ANIK) Change in Cash (2010 - 2026)
Anika Therapeutics (ANIK) posted quarterly Change in Cash of -$2.6 million for Q2 2026, down 1178.43% year-over-year from $241832.7 in Q2 2025, and up 84.16% quarter-over-quarter from -$16.5 million in Q1 2026.
Anika Therapeutics (ANIK) Change in Cash (2010 - 2026) Analysis & Trends
Anika Therapeutics (ANIK) has reported Change in Cash for 17 consecutive years, with -$2.6 million the latest figure, recorded in Q2 2026.
- In Q2 2026, Change in Cash fell 1178.43% year-over-year to -$2.6 million; the TTM figure through Jun 2026 stood at -$14.8 million (down 52.82% YoY), while the FY2025 annual figure was $322000.0, up 102.05% from the prior year.
- Change in Cash climbed to -$2.6 million in Q2 2026 per ANIK's latest filing, from -$16.5 million in the prior quarter.
- Across five years, Change in Cash topped out at $5.6 million in Q3 2023 and bottomed at -$16.5 million in Q1 2026.
- Historically, Change in Cash has averaged -$3.1 million across 5 years, with a median of -$3.1 million in 2022.
- Annual changes were most pronounced in 2023 — Change in Cash plunged 1474.51% — and 2025, when it surged 1162.33%.
- Anika Therapeutics' Change in Cash stood at -$1.4 million in 2022, then jumped by 252.83% to $2.2 million in 2023, then slumped by 335.06% to -$5.2 million in 2024, then surged by 90.23% to -$509000.0 in 2025, then slumped by 412.38% to -$2.6 million in 2026.
- Business Quant data shows ANIK's Change in Cash at -$2.6 million in Q2 2026, -$16.5 million in Q1 2026, and -$509000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.95 Bn | 39.30 Bn | 2.15 Bn | -86.00 Mn |
| 3 | Zoetis | 31.58 Bn | 29.90 Bn | 1.05 Bn | -465.00 Mn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -881.03 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.49 Bn | 683.80 Mn | 523.50 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -915.70 Mn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 64.40 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 102.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.95 Bn | - | - |
| 10 | Anika Therapeutics | 282.86 Mn | 244.45 Mn | 21.24 Mn | -2.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.61 Mn |
| Mar 31, 2026 | -16.46 Mn |
| Dec 31, 2025 | -509,000.00 |
| Sep 30, 2025 | 4.82 Mn |
| Jun 30, 2025 | -204,000.00 |
| Mar 31, 2025 | -3.79 Mn |
| Dec 31, 2024 | -5.21 Mn |
| Sep 30, 2024 | -454,000.00 |
| Jun 30, 2024 | -5.81 Mn |
| Mar 31, 2024 | -4.24 Mn |
| Dec 31, 2023 | 2.22 Mn |
| Sep 30, 2023 | 5.58 Mn |
| Jun 30, 2023 | -14.67 Mn |
| Mar 31, 2023 | -6.59 Mn |
| Dec 31, 2022 | -1.45 Mn |
| Sep 30, 2022 | -3.62 Mn |
| Jun 30, 2022 | 1.07 Mn |
| Mar 31, 2022 | -4.06 Mn |
| Dec 31, 2021 | 3.41 Mn |
| Sep 30, 2021 | -6.21 Mn |